ALLR vs HOLX · P/E 0.0, rev $25.0K vs P/E 32, rev $4.10B
Allarity Therapeutics Inc (ALLR) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the ALLR and HOLX stock pages for the full models.
Not investment advice.